Clinical Scorecard: Avoiding Billing and Documentation Pitfalls in IRD Coding

At a Glance

Key Highlights

• Many IRDs lack specific diagnosis codes, falling under broader categories.
• Documentation of signs, symptoms, and exam findings is crucial for diagnosis support.
• Common billing challenges include missing documentation and poorly edited notes.
• Testing must follow clinical guidelines and include relevant gene panels.
• Accurate documentation is essential to reduce denials and compliance risks.

Guideline-Based Recommendations

Diagnosis

• Utilize appropriate ICD-10 codes for IRDs, including unspecified hereditary retinal dystrophy and others.
• Expand coding for specific conditions like Usher syndrome by October 1, 2025.

Management

• Ensure that the provider ordering diagnostic tests is the one using the findings.
• Include medical indications, test modalities, and expected timeframes in test orders.

Monitoring & Follow-up

• Follow payer guidelines for the frequency of exams and testing.

Risks

• Inadequate documentation can lead to claim denials and compliance risks.

Patient & Prescribing Data

Individuals diagnosed with inherited retinal diseases.

Emerging genetic therapies require precise documentation and coding to ensure coverage.

Clinical Best Practices

• Maintain clear and comprehensive documentation for each patient visit.
• Link diagnostic test findings directly to the patient's diagnosis and treatment plan.
• Avoid using cloned or poorly edited notes to demonstrate disease progression.

References

• Elizabeth Cifers Consulting